April 2015 Respiratory Health

By educating nurses, counseling physicians, and providing feedback on inhalation technique, pharmacists can reduce issues related to salbutamol treatment for asthma and bronchitis, according to research findings.

Most patients who require inhalers for asthma or epinephrine autoinjectors for an allergic disease do not use the devices properly, according to a study.

Just 15% of employed adults with asthma consult with their health care professional on how work conditions might affect their disease, according to a new study.

A track-and-trace law that will go into effect on July 1, 2015, will hold pharmacies responsible for more data about their pharmacy shipments, as well as their process of managing illegitimate or suspect products.

During her studies at the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences, Madeline Waldron has demonstrated a natural aptitude toward leadership.

Read about practical tools for research, patient counseling, and professional development.

A study investigating allergic reactions in mice has indicated that estrogen plays a role in triggering anaphylaxis, providing a potential clue as to why women experience severe allergic reactions more frequently than men.

Sufferers of spring allergies may be able to reduce their seasonal flareups by lowering their stress level, according to a study.

Introducing peanut products into the diets of infants can reduce their risk of developing a peanut allergy, a study suggests.

Few pharmacies create succession plans to fortify their organizations, plans that outline training for qualified staff to assume leadership responsibilities.

Read about the new generic products featured in April.

People of all ages can develop acne, but many treatments are available.

With prescription opioid overdoses leading to more deaths in the United States each year than cocaine and heroin combined, prescription drug abuse, misuse, and diversion have become growing concerns.

The FDA has published 60 product-specific recommendations outlining its attitudes and expectations for developing therapeutically equivalent generic medicines.

The lack of generic insulin may keep patients from using the medicine, even though they risk life-threatening complications, new research from Johns Hopkins University School of Medicine suggests.

The FDA's March 6, 2015, Zarxio approval brought biosimilars into the spotlight once again, although Zarxio and other biosimilars continue to face hurdles. Community pharmacists should remain aware of the therapies in order to better assist their patients.

If a pharmaceutical manufacturer markets a medication via interstate commerce and then reduces production and rations availability of the medication, can a lawsuit proceed that alleges negligence?

With multiple pharmaceutical manufacturers now entering the market with abuse-deterrent formulations of opiate pain relievers, insurance carriers are getting up in arms at the costs of these drugs.

Chronic obstructive pulmonary disease Is preventable and treatable, especially if diagnosed early.

Whether its robots, microbots, smartphones, or 3-dimensional printing, the potential for technology to impact health care and pharmacy excites and motivates Dan Benamoz, RPh, founder and chief executive officer, Pharmacy Development Services.

Patients who suffer from chronic conditions are at a higher risk for medical-related episodes and errors.

Pharmacists can make a significant difference in the treatment of patients with sinusitis.

Read about the new Rx Products featured in April.

The FDA has approved GlaxoSmithKline's Tanzeum (albiglutide) subcutaneous injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Efforts are being made to ensure that health care providers deliver the right care at the right time.

The route of administration has been recognized as an important variable for drug interactions.